Role of DNA repair-related gene polymorphisms in susceptibility to risk of prostate cancer

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 5839-5842

  Yang, Bo ^a   Chen, Wei hua ^b   Wen, Xiao fei ^b   Liu, Hui ^a   Liu, Feng ^a  

^a Shanghai Pudong New Area Zhoupu Hospital   (China)

^b Tongji University   (China)

Author keywords

CSB; DNA repair; Polymorphism; Prostate cancer; Related genes; XPG

Indexed keywords

AGED; ALLELE; CASE CONTROL STUDY; CLINICAL TRIAL; DNA REPAIR; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MULTICENTER STUDY; PROSTATE TUMOR; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; CASE-CONTROL STUDIES; DNA REPAIR; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK;

EID: 84890455191     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.5839     Document Type: Article

References (27)

1. Agalliu I, Kwon EM, Salinas CA, et al (2010). Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control, 21, 289-300.
2. Berhane N Sobti RC, Mahdi SA (2012). DNA repair genes polymorphism (XPG and XRCC1) and association of prostate cancer in a north Indian population. Mol Biol Rep, 39, 2471-9.
3. Chang CH Chiu CF, Wang HC, et al (2009). Significant association of ERCC6 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan. Anticancer Res, 29, 5121-4.
4. Chen J Cui X, Zhou H, et al (2013). Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study. BMC Cancer, 13, 356.
5. Dizdaroglu M (2012). Oxidatively induced DNA damage: mechanisms, repair and disease. Cancer Lett, 327, 26-47.
6. Farrell J, Petrovics G, McLeod DG, Srivastava S (2013). Genetic and Molecular Differences in Prostate Carcinogenesis between African American and Caucasian American Men. Int J Mol Sci, 14, 15510-31.
7. Grant WB (2004). A multi country ecologic study of risk and risk reduction factors for prostate cancer mortality. Eur Urol, 45, 271-9.
8. Globocan 2008 (2008). Prostate Cancer Incidence, Mortality and Prevalence Worldwide in 2008. http://globocan.iarc.fr/factsheet.asp. International Agency for Research on Cancer.
9. Goode EL, Ulrich CM, Potter JD (2002). Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 1513-30.
10. Grunda JM, Fiveash J, Palmer CA, et al (2010). Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcome. Clin Cancer Res, 16, 2890-8.
11. Hooker S, Bonilla C, Akereyeni F, Ahaghotu C, Kittles RA (2008). NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans. Prostate Cancer Prostatic Dis, 11, 349-56.
12. Hu JJ, Mohrenweiser HW, Bell DA, Leadon SA, Miller MS (2002). Symposium overview: genetic polymorphisms in DNA repair and cancer risk. Toxicol Appl Pharmacol, 185, 64-73.
13. Hu JJ. Hall MC, Grossman L, et al (2004). Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res, 64, 1197-201.
14. Hyytinen ER, Frierson HF Jr, Sipe TW, et al (1999). Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer. Prostate, 41, 190-5.
15. Liao SG, Liu L, Wang Y, et al (2012). XPD Asp312Asn polymorphism is a risk factor for prostate cancer. J Cancer Res Clin Oncol, 138, 1689-95.
16. Mittal RD, Mandal RK (2012). Genetic variation in nucleotide excision repair pathway genes influence prostate and bladder cancer susceptibility in North Indian population. Indian J Hum Genet, 18, 47-55.
17. Neumann AS, Sturgis EM, Wei Q (2005). Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol Carcinog, 42, 65-92.
18. Nock NL, Cicek MS, Li L, et al (2006). Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk. Carcinogenesis, 27, 1842-8.
19. Priyadarshini A, Chakraborti A, Mandal AK, Singh SK (2013). Asp299Gly and Thr399Ile polymorphism of TLR-4 gene in patients with prostate cancer from North India. Indian J Urol, 29, 37-41.
20. Rybicki BA, Nock NL, Savera AT, Tang D, Rundle A (2006). Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis. Cancer Lett, 239, 157-67.
21. Singh KP, Kumari R, Treas J, DuMond JW (2011). Chronic exposure to arsenic causes increased cell survival, DNA damage, and increased expression of mitochondrial transcription factor A (mtTFA) in human prostate epithelial cells. Chem Res Toxicol, 24, 340-9.
22. Smith TR, Miller MS, Lohman K, et al (2003). Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett, 190, 183-90.
23. Sobti RC, Berhane N, Melese S, et al (2012). Impact of XPD gene polymorphism on risk of prostate cancer on north Indian population. Mol Cell Biochem, 362, 263-8.
24. Sun XH, Hou WG, Zhao HX, et al (2013). Single nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumors. Asian Pac J Cancer Prev, 14, 2049-52.
25. Tang D, Liu JJ, Rundle A, et al (2007) Grilled meat consumption and PhIP-DNA adducts in prostate carcinogenesis. Cancer Epidemiol Biomark Prev, 16, 803-8.
26. Wheless L, Kistner-Griffin E, Jorgensen TJ, et al (2012). A community-based study of nucleotide excision repair polymorphisms in relation to the risk of non-melanoma skin cancer. J Invest Dermatol, 132, 1354-62.
27. Wu Q, Christensen LA, Legerski RJ, Vasquez KM (2005). Mismatch repair participates in error-free processing of DNA interstrand crosslinks in human cells. EMBO Rep, 6, 551-7.